Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...
The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving ...
CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The Centers for Medicare & Medicaid Services has changed course on plans to appeal a court ruling that determined it must ...
The Ohio Department of Medicaid is preparing to submit a change to its program that would cost at least 60,000 people their ...
UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...
Expanding eligibility for MSPs is an important avenue to support health care affordability for older low-income adults, ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...